Core Insights - The company has sold 1.7517 million pigs from January to July 2025, achieving approximately 50% of its target output, and is confident in meeting its established goals for the year [1] - The company plans to implement several measures to ensure steady growth in pig output, including advancing a 300,000-head breeding project, optimizing the sow population structure, and establishing a comprehensive biosecurity system [1] - The company is closely monitoring industry policies and market supply-demand changes, aiming to enhance production efficiency and reduce costs through refined management practices and hedging tools to mitigate market price fluctuations [1] Measures for Production Growth - The company is actively promoting a breeding project in the 37th regiment of the Second Division of the Xinjiang Production and Construction Corps, expected to be operational in the second half of 2025 [1] - The company aims to optimize the sow population by scientifically selecting and eliminating low-yield sows to improve reproductive performance and production efficiency [1] - A comprehensive biosecurity system will be constructed, covering site selection, disinfection protocols, vaccination, and health monitoring to ensure the health of the pig population [1] Market Strategy - The company is focused on closely monitoring industry policy dynamics and market supply-demand changes [1] - It plans to enhance production efficiency and reduce costs through meticulous breeding management and feed cost control [1] - The company will utilize hedging tools to address market price volatility, thereby strengthening its competitiveness and risk resistance for long-term stable development [1]
天康生物:2025年1-7月,公司累计销售生猪175.17万头,目前已完成50%左右的目标出栏量